Exiqon Licenses microRNA IP From Max Planck Society, Rockefeller University | GenomeWeb
NEW YORK (GenomeWeb News) – Exigon has licensed more than 200 human and viral microRNA sequences for diagnostic applications from Rockefeller University and the Max Planck Society, the company said today. 

The two separate, co-exclusive license agreements were signed with Garching Innovation, the technology-transfer agency of the society and the university.

 
Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.